Tudor Investment Corp
KRYS icon

Tudor Investment Corp’s Krystal Biotech KRYS Stock Holding History

Tudor Investment Corp’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.74M Buy
14,476
+13,101
+953% +$3.49M 0.01% 1374
2025
Q4 		$339K Buy
+1,375
New +$289K ﹤0.01% 2963
2022
Q4 		– Sell
-11,546
Closed -$805K – 2642
2022
Q3 		$805K Buy
+11,546
New +$834K 0.02% 1066
2022
Q1 		– Sell
-12,562
Closed -$879K – 2375
2021
Q4 		$879K Buy
+12,562
New +$731K 0.01% 1090

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tudor Investment Corp's KRYS Position: Q1 2026 in Review

Tudor Investment Corp increased its Krystal Biotech (KRYS) stake by 953% in Q1 2026, buying an estimated $3.49M and bringing the position to 14,476 shares worth $3.74M. The position accounts for 0.01% of the portfolio, ranked #1374.

Tudor Investment Corp first reported a position in KRYS in Q4 2021 and has held it in 4 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Tudor Investment Corp held 14,476 shares of Krystal Biotech worth $3.74M as of Q1 2026.
  • Tudor Investment Corp bought 13,101 Krystal Biotech shares in Q1 2026, an estimated $3.49M.
  • Krystal Biotech made up 0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #1374 holding.
  • Tudor Investment Corp first reported a position in Krystal Biotech in Q4 2021 and has held it in 4 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.